Role Summary
Senior Vice President of Market Access at BridgeBio, accountable for developing and executing strategies that optimize patient access, reimbursement, availability, and affordability for the U.S. portfolio of rare-disease and specialty therapies. Serves as an enterprise leader on U.S. market access, leading pricing, access, reimbursement, distribution, HEOR, and affordability programs, and partnering across the organization to advance patient outcomes. This is an onsite role requiring in-office collaboration 2-3 days per week in the San Francisco office.
Responsibilities
- Lead, develop, and inspire a high-performing team, fostering an inclusive environment where people are empowered to do their best work in service of patients
- Provide enterprise leadership on U.S. portfolio- and product-level pricing, access, reimbursement, distribution, HEOR and affordability strategies, spanning in-line products, lifecycle management, and future pipeline planning
- Serve as a senior leader within the U.S. organization, contributing to both financial performance and long-term patient impact, and helping to shape BridgeBio’s commercial strategy as we grow
- Partner closely with cross-functional stakeholders including Commercial, Medical Affairs, Legal, Finance, CMC, and Government Affairs to anticipate and respond to market, policy, and regulatory dynamics affecting patient access
- Lead efforts to negotiate complex agreements across payers, PBMs, specialty and retail pharmacies, GPOs, and distribution partners
- Build and oversee industry-leading patient and reimbursement support programs, leveraging technology, data, and human-centered design to reduce friction for patients, caregivers, and providers
Qualifications
- Bachelor’s degree in business, healthcare, or a related field; advanced degree strongly preferred
- 15+ years of experience within a pharmaceutical or biotechnology organization, with a demonstrated track record of building and leading high-impact teams and delivering meaningful business and patient outcomes
- 10+ years of direct leadership experience in U.S. Market Access, with exposure to complex portfolios including specialty and/or rare disease products; global or ex-U.S. experience is a plus
- Deep understanding of the U.S. healthcare ecosystem, including payer, PBM, GPO, specialty pharmacy, distributor, and provider dynamics, and proven experience navigating challenging reimbursement and access scenarios
- Established executive-level relationships with key U.S. access stakeholders and a reputation for credibility, transparency, and principled negotiation
- You have demonstrated curiosity and adaptability in adopting AI-powered tools and technologies